Department of Pharmacology and Toxicology and Nicolas V. Perricone Division of Dermatology, Department of Medicine, Michigan State University, East Lansing, Michigan.
Department of Pathology, Stephenson Cancer Center, and Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Am J Pathol. 2021 Aug;191(8):1342-1352. doi: 10.1016/j.ajpath.2021.02.006. Epub 2021 Feb 24.
The role of the adipocyte in the tumor microenvironment has received significant attention as a critical mediator of the obesity-cancer relationship. Current estimates indicate that 650 million adults have obesity, and thirteen cancers, including breast cancer, are estimated to be associated with obesity. Even in people with a normal body mass index, adipocytes are key players in breast cancer progression because of the proximity of tumors to mammary adipose tissue. Outside the breast microenvironment, adipocytes influence metabolic and immune function and produce numerous signaling molecules, all of which affect breast cancer development and progression. The current epidemiologic data linking obesity, and importantly adipose tissue, to breast cancer risk and prognosis, focusing on metabolic health, weight gain, and adipose distribution as underlying drivers of obesity-associated breast cancer is presented here. Bioactive factors produced by adipocytes, both normal and cancer associated, such as cytokines, growth factors, and metabolites, and the potential mechanisms through which adipocytes influence different breast cancer subtypes are highlighted.
脂肪细胞在肿瘤微环境中的作用作为肥胖与癌症关系的关键介质受到了极大关注。目前估计有 6.5 亿成年人肥胖,有 13 种癌症,包括乳腺癌,被认为与肥胖有关。即使在体重指数正常的人群中,由于肿瘤靠近乳腺脂肪组织,脂肪细胞也是乳腺癌进展的关键参与者。在乳腺微环境之外,脂肪细胞影响代谢和免疫功能,并产生许多信号分子,所有这些都影响乳腺癌的发生和发展。这里介绍了目前将肥胖,尤其是脂肪组织与乳腺癌风险和预后联系起来的流行病学数据,重点关注代谢健康、体重增加和脂肪分布作为肥胖相关乳腺癌的潜在驱动因素。强调了脂肪细胞产生的生物活性因子,包括正常和与癌症相关的细胞因子、生长因子和代谢物,以及脂肪细胞影响不同乳腺癌亚型的潜在机制。